Celldex Therapeutics, Inc. (CLDX)
30.73
+0.15
(+0.49%)
USD |
NASDAQ |
May 22, 16:00
30.72
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics EPS Diluted (TTM) : -4.267 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Plus Therapeutics, Inc. | -3.267 |
| Perspective Therapeutics, Inc. | -1.396 |
| Myriad Genetics, Inc. | -4.316 |
| Atossa Therapeutics, Inc. | -4.370 |
| AVITA Medical, Inc. | -1.570 |